1,490
Views
21
CrossRef citations to date
0
Altmetric
Laboratory Study

The protective effects of rapamycin on cell autophagy in the renal tissues of rats with diabetic nephropathy via mTOR-S6K1-LC3II signaling pathway

, , , , &
Pages 492-497 | Received 05 Dec 2017, Accepted 07 Jun 2018, Published online: 11 Sep 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jiayong Xie, Ying Yuan, Gang Yao, Zhi Chen, Wenjuan Yu & Qiang Zhu. (2021) Nucleoporin 160 (NUP160) inhibition alleviates diabetic nephropathy by activating autophagy. Bioengineered 12:1, pages 6390-6402.
Read now

Articles from other publishers (20)

Yi Chen, Yashpal S. Kanwar, Xueqin Chen & Ming Zhan. (2024) Aging and Diabetic Kidney Disease: Emerging Pathogenetic Mechanisms and Clinical Implications. Current Medicinal Chemistry 31:6, pages 697-725.
Crossref
Che-Hao Tseng, Kavya M. Shah, I-Jen Chiu & Li-Li Hsiao. (2023) The Role of Autophagy in Type 2 Diabetic Kidney Disease Management. Cells 12:23, pages 2691.
Crossref
Weiyan Lai, Dan Luo, Yin Li, Yuanqing Li, Qianqian Wang, Zhaoyong Hu, Zengchun Ye & Hui Peng. (2023) Irisin ameliorates diabetic kidney disease by restoring autophagy in podocytes. The FASEB Journal 37:10.
Crossref
Yu Wang, Mingyue Jin, Chak Kwong Cheng & Qiang Li. (2023) Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives. Frontiers in Endocrinology 14.
Crossref
Yu-Peng Han, Li-Juan Liu, Jia-Lin Yan, Meng-Yuan Chen, Xiang-Fei Meng, Xin-Ru Zhou & Ling-Bo Qian. (2023) Autophagy and its therapeutic potential in diabetic nephropathy. Frontiers in Endocrinology 14.
Crossref
Moein Ala. (2023) Sestrin2 Signaling Pathway Regulates Podocyte Biology and Protects against Diabetic Nephropathy. Journal of Diabetes Research 2023, pages 1-15.
Crossref
Xiujie Shi, Meiying Chang, Mingming Zhao, Yue Shi & Yu Zhang. (2022) Traditional Chinese medicine compounds ameliorating glomerular diseases via autophagy: A mechanism review. Biomedicine & Pharmacotherapy 156, pages 113916.
Crossref
Marziyeh Salami, Raziyeh Salami, Alireza Mafi, Mohammad-Hossein Aarabi, Omid Vakili & Zatollah Asemi. (2022) Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling. Current Molecular Pharmacology 15:5, pages 716-735.
Crossref
Jiayi Xu, Xiaomeng Shan, Chunwei Chen, Yanbin Gao, Dawei Zou, Xiaolei Wang, Tao Wang & Yimin Shi. (2022) Tangshenning Attenuates High Glucose-Induced Podocyte Injury via Restoring Autophagy Activity through Inhibiting mTORC1 Activation. Journal of Diabetes Research 2022, pages 1-11.
Crossref
Quanhui Tan, Jie chen, Gao Gao, Yizhang, Xiaohua Chen, Yongsheng Yu, Guoqin Zang & Zhenghao Tang. (2022) Adenovirus vector encoding TPPII ignites HBV‐specific CTL response by activating autophagy in CD8+ T cell. Journal of Viral Hepatitis 29:3, pages 178-188.
Crossref
Hyun Jin Jung, Hyun-Jin An, Mi-Gyeong Gwon, Hyemin Gu, Seongjae Bae, Sun-Jae Lee, Young-Ah Kim, Jaechan Leem & Kwan-Kyu Park. (2022) Anti-Fibrotic Effect of Synthetic Noncoding Oligodeoxynucleotide for Inhibiting mTOR and STAT3 via the Regulation of Autophagy in an Animal Model of Renal Injury. Molecules 27:3, pages 766.
Crossref
Yanji Zhu, Min Liu, Wenlong Xun, Keliang Li & Xiangji Niu. (2021) P2X7R antagonist protects against renal injury in mice with adriamycin nephropathy. Experimental and Therapeutic Medicine 23:2.
Crossref
Jiwon M. Lee, Andreas Kronbichler, Jae Il Shin & Jun Oh. (2020) Current understandings in treating children with steroid-resistant nephrotic syndrome. Pediatric Nephrology 36:4, pages 747-761.
Crossref
Dongjun Li, Denghui Wang & Shikai Yan. (2021) Exploration of underlying molecular mechanism of Lycii Cortex in Treating Type 2 Diabetes Mellitus Based on Network Pharmacology and Molecular Docking . E3S Web of Conferences 233, pages 02007.
Crossref
Qiuer Liang, Tianhao Liu, Tingting Guo, Wencong Tao, Xudong Chen, Weihao Chen, Liguo Chen & Ya Xiao. (2021) ATF4 promotes renal tubulointerstitial fibrosis by suppressing autophagy in diabetic nephropathy. Life Sciences 264, pages 118686.
Crossref
Elias A. T. Koch, Rola Nakhoul, Farid Nakhoul & Nakhoul Nakhoul. (2020) Autophagy in diabetic nephropathy: a review. International Urology and Nephrology 52:9, pages 1705-1712.
Crossref
Lili Zhang, Zhige Wen, Lin Han, Yujiao Zheng, Yu Wei, Xinmiao Wang, Qing Wang, Xinyi Fang, Linhua Zhao & Xiaolin Tong. (2020) Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy. Journal of Diabetes Research 2020, pages 1-15.
Crossref
A. O. Shpakov & E. V. Kaznacheyeva. (2020) Molecular Mechanisms of Apoptosis of Glomerular Podocytes in Diabetic Nephropathy. Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology 14:3, pages 205-222.
Crossref
Jiang Xu, Lin‐Qing Liu, Lin‐Lin Xu, Yan Xing & Shandong Ye. (2020) Metformin alleviates renal injury in diabetic rats by inducing Sirt1/FoxO1 autophagic signal axis. Clinical and Experimental Pharmacology and Physiology 47:4, pages 599-608.
Crossref
Dan-Yang Zhao, Dong-Dong Yu, Li Ren & Guo-Rong Bi. (2020) Ligustilide protects PC12 cells from oxygen-glucose deprivation/reoxygenation-induced apoptosis via the LKB1-AMPK-mTOR signaling pathway. Neural Regeneration Research 15:3, pages 473.
Crossref